Shell restarts production at Penguins field in UK North Sea-March 2024-www.financetom.com

Shell restarts production at Penguins field in UK North Sea

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Shell restarts production at Penguins field in UK North Sea

Feb 4, 2025 1:59 AM

Feb 4 (Reuters) - Shell said on Tuesday it has

restarted production at the Penguins field in the UK North Sea

with a modern floating, production, storage and offloading

(FPSO) facility.

Previous page： Jefferies Financial Fiscal Fourth-Quarter Results Rise Annually Amid Investment Banking Strength Next page： Delta forecasts the strongest profit in its 100-year history

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Jefferies Financial Fiscal Fourth-Quarter Results Rise Annually Amid Investment Banking Strength

Jan 10, 2025

06:34 AM EST, 01/10/2025 (MT Newswires) -- Jefferies Financial Group's ( JEF ) fiscal fourth-quarter results rose year over year driven by gains across its investment banking and asset management divisions. The financial services company's earnings came in at $0.93 per share for the quarter ended November, up from $0.29 the year before, it said Wednesday. Four analysts surveyed by...

Delta forecasts the strongest profit in its 100-year history

Jan 10, 2025

* Delta reports higher-than-expected Q4 profit, forecasts strong Q1 earnings * Premium travel demand boosts Delta's revenue growth * Reduced airline seats drive up ticket prices, benefiting Delta's earnings By Rajesh Kumar Singh CHICAGO, Jan 10 (Reuters) - Delta Air Lines ( DAL ) said on Friday it expects 2025 to be the most profitable year in the company's 100-year...

Mersana Therapeutics Says Initial Data From Cancer Drug Trial Shows Promise, Shares Rise Premarket

Jan 10, 2025

06:37 AM EST, 01/10/2025 (MT Newswires) -- Mersana Therapeutics ( MRSN ) said Friday initial clinical data from the phase 1 study of its lead candidate, emiltatug ledadotin, targeting B7-H4, showed clinical activity across multiple tumor types and was well tolerated among patients. The company said the dose escalation portion of the trial enrolled 130 patients with advanced/metastatic cancers, including...

Delta forecasts strongest profit in its 100-year history

Jan 10, 2025

CHICAGO (Reuters) -Delta Air Lines ( DAL ) said on Friday it expects 2025 to be the most profitable year in the company's 100-year history, thanks to robust demand for premium travel as well as the industry's improved pricing power. The U.S. carrier also reported a higher-than-expected fourth quarter profit and forecast stronger earnings in the current quarter. Shares of...